Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:30Keyera May 2025 slides: 7-8% EBITDA growth projected through 2027
13:30SINTX Technologies refocuses on medical device market
13:30North American Construction Group Q1 2025 slides: Revenue up 13%, but margins compress
13:30Ferrexpo faces bankruptcy application for Ukrainian unit
13:30Bragg Gaming Q1 2025 slides: Proprietary content drives 20% profit growth, margin expansion
13:30Invivyd Q1 2025 slides: Revenue grows amid regulatory hurdles and cash concerns
13:30Highcroft Shareholders Approve LondonMetric Acquisition
13:30Marex Q1 2025 presentation slides: 42% profit growth amid market expansion
13:30Stantec Q1 2025 presentation: Net revenue up 13.3%, EPS jumps 28.9%
13:30DXC Technology stock target cut to $18 at RBC Capital
13:30BofA cuts Virtu Financial stock rating to Neutral, sets $43 target
13:18U.K. consumer spending rises, discretionary purchases lead the way: Barclays
13:18T1 Energy Q1 2025 slides: slashes 2025 outlook amid policy uncertainties
13:18Alpha Group shareholders approve resolutions at AGM
13:18GVS Q1 2025 presentation: Sales up 3.2%, Healthcare division leads growth
13:18Walmart Q1 FY26 presentation slides: eCommerce surge drives 4% revenue growth
13:18Acuren and NV5 announce $1.7 billion merger deal
13:18Hikma forecasts revenue growth, sets $5 billion target by 2030
13:18Amaroq Minerals proposes company name change, sets meeting date
13:18Grenke Q1 2025 slides: New business up 10.6%, earnings drop on higher provisions
13:18Trust Stamp and Partisia form partnership for digital identity tech
13:18H.C. Wainwright sets $8 target for Acurx Pharmaceuticals stock
13:06TSX futures inch lower after index rises for seventh-straight session
13:06Merck's Keytruda shows promise in ovarian cancer trial
13:06Shelly Group Q1 2025 slides: revenue growth exceeds guidance, product expansion accelerates